 | • レポートコード：MRC2012B0888 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、核医学の世界市場を広く調査・分析し、今後の市場展望をまとめております。核医学の種類別市場規模（Tc-99、I-123/131、In-111、Xe-133、Th-201、Ga-67、その他）、用途別市場規模（診断、治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GE Healthcare、Jubilant Pharma、Lantheus Medical Imaging、Bracco Imaging、Nordion、Mallinckrodt、SIEMENS、Triad Isotopes、Bayer、Eli Lilly、China Isotope & Radiation、Dongcheng、 ・地域別グローバル市場分析 2015年-2020年 ・核医学の北米市場（アメリカ、カナダ、メキシコ） ・核医学のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・核医学のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・核医学の南米市場（ブラジル、アルゼンチン） ・核医学の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：Tc-99、I-123/131、In-111、Xe-133、Th-201、Ga-67、その他 ・用途別分析：診断、治療 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Nuclear Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Nuclear Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 7219.3 million by 2025, from USD 5490.7 million in 2019.
Market segmentation
Nuclear Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nuclear Medicine market has been segmented into:
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
By Application, Nuclear Medicine has been segmented into:
Diagnostic
Therapeutic
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Medicine market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Medicine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Medicine market.
The report offers in-depth assessment of the growth and other aspects of the Nuclear Medicine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Nuclear Medicine Market Share Analysis
Nuclear Medicine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nuclear Medicine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Medicine sales, revenue and market share for each player covered in this report.
The major players covered in Nuclear Medicine are:
GE Healthcare
Jubilant Pharma
Lantheus Medical Imaging
Bracco Imaging
Nordion
Mallinckrodt
SIEMENS
Triad Isotopes
Bayer
Eli Lilly
China Isotope & Radiation
Dongcheng
Among other players domestic and global, Nuclear Medicine market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Nuclear Medicine Market Overview
1.1 Product Overview and Scope of Nuclear Medicine
1.2 Classification of Nuclear Medicine by Type
1.2.1 Global Nuclear Medicine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nuclear Medicine Revenue Market Share by Type in 2019
1.2.3 Tc-99
1.2.4 I-123/131
1.2.5 In-111
1.2.6 Xe-133
1.2.7 Th-201
1.2.8 Ga-67
1.2.9 Other
1.3 Global Nuclear Medicine Market by Application
1.3.1 Overview: Global Nuclear Medicine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Global Nuclear Medicine Market by Regions
1.4.1 Global Nuclear Medicine Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nuclear Medicine (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nuclear Medicine Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nuclear Medicine Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nuclear Medicine Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nuclear Medicine Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nuclear Medicine Status and Prospect (2015-2025)
2 Company Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business
2.1.3 GE Healthcare SWOT Analysis
2.1.4 GE Healthcare Product and Services
2.1.5 GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.2 Jubilant Pharma
2.2.1 Jubilant Pharma Details
2.2.2 Jubilant Pharma Major Business
2.2.3 Jubilant Pharma SWOT Analysis
2.2.4 Jubilant Pharma Product and Services
2.2.5 Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.3 Lantheus Medical Imaging
2.3.1 Lantheus Medical Imaging Details
2.3.2 Lantheus Medical Imaging Major Business
2.3.3 Lantheus Medical Imaging SWOT Analysis
2.3.4 Lantheus Medical Imaging Product and Services
2.3.5 Lantheus Medical Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bracco Imaging
2.4.1 Bracco Imaging Details
2.4.2 Bracco Imaging Major Business
2.4.3 Bracco Imaging SWOT Analysis
2.4.4 Bracco Imaging Product and Services
2.4.5 Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.5 Nordion
2.5.1 Nordion Details
2.5.2 Nordion Major Business
2.5.3 Nordion SWOT Analysis
2.5.4 Nordion Product and Services
2.5.5 Nordion Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mallinckrodt
2.6.1 Mallinckrodt Details
2.6.2 Mallinckrodt Major Business
2.6.3 Mallinckrodt Product and Services
2.6.4 Mallinckrodt Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.7 SIEMENS
2.7.1 SIEMENS Details
2.7.2 SIEMENS Major Business
2.7.3 SIEMENS Product and Services
2.7.4 SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.8 Triad Isotopes
2.8.1 Triad Isotopes Details
2.8.2 Triad Isotopes Major Business
2.8.3 Triad Isotopes Product and Services
2.8.4 Triad Isotopes Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Product and Services
2.9.4 Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Product and Services
2.10.4 Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.11 China Isotope & Radiation
2.11.1 China Isotope & Radiation Details
2.11.2 China Isotope & Radiation Major Business
2.11.3 China Isotope & Radiation Product and Services
2.11.4 China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
2.12 Dongcheng
2.12.1 Dongcheng Details
2.12.2 Dongcheng Major Business
2.12.3 Dongcheng Product and Services
2.12.4 Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nuclear Medicine Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nuclear Medicine Players Market Share
3.2.2 Top 10 Nuclear Medicine Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nuclear Medicine Revenue and Market Share by Regions
4.2 North America Nuclear Medicine Revenue and Growth Rate (2015-2020)
4.3 Europe Nuclear Medicine Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nuclear Medicine Revenue and Growth Rate (2015-2020)
4.5 South America Nuclear Medicine Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nuclear Medicine Revenue and Growth Rate (2015-2020)
5 North America Nuclear Medicine Revenue by Countries
5.1 North America Nuclear Medicine Revenue by Countries (2015-2020)
5.2 USA Nuclear Medicine Revenue and Growth Rate (2015-2020)
5.3 Canada Nuclear Medicine Revenue and Growth Rate (2015-2020)
5.4 Mexico Nuclear Medicine Revenue and Growth Rate (2015-2020)
6 Europe Nuclear Medicine Revenue by Countries
6.1 Europe Nuclear Medicine Revenue by Countries (2015-2020)
6.2 Germany Nuclear Medicine Revenue and Growth Rate (2015-2020)
6.3 UK Nuclear Medicine Revenue and Growth Rate (2015-2020)
6.4 France Nuclear Medicine Revenue and Growth Rate (2015-2020)
6.5 Russia Nuclear Medicine Revenue and Growth Rate (2015-2020)
6.6 Italy Nuclear Medicine Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nuclear Medicine Revenue by Countries
7.1 Asia-Pacific Nuclear Medicine Revenue by Countries (2015-2020)
7.2 China Nuclear Medicine Revenue and Growth Rate (2015-2020)
7.3 Japan Nuclear Medicine Revenue and Growth Rate (2015-2020)
7.4 Korea Nuclear Medicine Revenue and Growth Rate (2015-2020)
7.5 India Nuclear Medicine Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nuclear Medicine Revenue and Growth Rate (2015-2020)
8 South America Nuclear Medicine Revenue by Countries
8.1 South America Nuclear Medicine Revenue by Countries (2015-2020)
8.2 Brazil Nuclear Medicine Revenue and Growth Rate (2015-2020)
8.3 Argentina Nuclear Medicine Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nuclear Medicine by Countries
9.1 Middle East & Africa Nuclear Medicine Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nuclear Medicine Revenue and Growth Rate (2015-2020)
9.3 UAE Nuclear Medicine Revenue and Growth Rate (2015-2020)
9.4 Egypt Nuclear Medicine Revenue and Growth Rate (2015-2020)
9.5 South Africa Nuclear Medicine Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nuclear Medicine Revenue and Market Share by Type (2015-2020)
10.2 Global Nuclear Medicine Market Forecast by Type (2019-2024)
10.3 Tc-99 Revenue Growth Rate (2015-2025)
10.4 I-123/131 Revenue Growth Rate (2015-2025)
10.5 In-111 Revenue Growth Rate (2015-2025)
10.6 Xe-133 Revenue Growth Rate (2015-2025)
10.7 Th-201 Revenue Growth Rate (2015-2025)
10.8 Ga-67 Revenue Growth Rate (2015-2025)
10.9 Other Revenue Growth Rate (2015-2025)
11 Global Nuclear Medicine Market Segment by Application
11.1 Global Nuclear Medicine Revenue Market Share by Application (2015-2020)
11.2 Nuclear Medicine Market Forecast by Application (2019-2024)
11.3 Diagnostic Revenue Growth (2015-2020)
11.4 Therapeutic Revenue Growth (2015-2020)
12 Global Nuclear Medicine Market Size Forecast (2021-2025)
12.1 Global Nuclear Medicine Market Size Forecast (2021-2025)
12.2 Global Nuclear Medicine Market Forecast by Regions (2021-2025)
12.3 North America Nuclear Medicine Revenue Market Forecast (2021-2025)
12.4 Europe Nuclear Medicine Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nuclear Medicine Revenue Market Forecast (2021-2025)
12.6 South America Nuclear Medicine Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nuclear Medicine Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Nuclear Medicine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nuclear Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nuclear Medicine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nuclear Medicine Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Nuclear Medicine Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. GE Healthcare Corporate Information, Location and Competitors
Table 7. GE Healthcare Nuclear Medicine Major Business
Table 8. GE Healthcare Nuclear Medicine Total Revenue (USD Million) (2017-2018)
Table 9. GE Healthcare SWOT Analysis
Table 10. GE Healthcare Nuclear Medicine Product and Solutions
Table 11. GE Healthcare Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Jubilant Pharma Corporate Information, Location and Competitors
Table 13. Jubilant Pharma Nuclear Medicine Major Business
Table 14. Jubilant Pharma Nuclear Medicine Total Revenue (USD Million) (2018-2019)
Table 15. Jubilant Pharma SWOT Analysis
Table 16. Jubilant Pharma Nuclear Medicine Product and Solutions
Table 17. Jubilant Pharma Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Lantheus Medical Imaging Corporate Information, Location and Competitors
Table 19. Lantheus Medical Imaging Nuclear Medicine Major Business
Table 20. Lantheus Medical Imaging Nuclear Medicine Total Revenue (USD Million) (2017-2018)
Table 21. Lantheus Medical Imaging SWOT Analysis
Table 22. Lantheus Medical Imaging Nuclear Medicine Product and Solutions
Table 23. Lantheus Medical Imaging Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Bracco Imaging Corporate Information, Location and Competitors
Table 25. Bracco Imaging Nuclear Medicine Major Business
Table 26. Bracco Imaging Nuclear Medicine Total Revenue (USD Million) (2017-2018)
Table 27. Bracco Imaging SWOT Analysis
Table 28. Bracco Imaging Nuclear Medicine Product and Solutions
Table 29. Bracco Imaging Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Nordion Corporate Information, Location and Competitors
Table 31. Nordion Nuclear Medicine Major Business
Table 32. Nordion Nuclear Medicine Total Revenue (USD Million) (2017-2018)
Table 33. Nordion SWOT Analysis
Table 34. Nordion Nuclear Medicine Product and Solutions
Table 35. Nordion Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Mallinckrodt Corporate Information, Location and Competitors
Table 37. Mallinckrodt Nuclear Medicine Major Business
Table 38. Mallinckrodt Nuclear Medicine Total Revenue (USD Million) (2017-2018)
Table 39. Mallinckrodt SWOT Analysis
Table 40. Mallinckrodt Nuclear Medicine Product and Solutions
Table 41. Mallinckrodt Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. SIEMENS Corporate Information, Location and Competitors
Table 43. SIEMENS Nuclear Medicine Major Business
Table 44. SIEMENS Nuclear Medicine Total Revenue (USD Million) (2017-2018)
Table 45. SIEMENS SWOT Analysis
Table 46. SIEMENS Nuclear Medicine Product and Solutions
Table 47. SIEMENS Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Triad Isotopes Corporate Information, Location and Competitors
Table 49. Triad Isotopes Nuclear Medicine Major Business
Table 50. Triad Isotopes Nuclear Medicine Total Revenue (USD Million) (2017-2018)
Table 51. Triad Isotopes SWOT Analysis
Table 52. Triad Isotopes Nuclear Medicine Product and Solutions
Table 53. Triad Isotopes Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Bayer Corporate Information, Location and Competitors
Table 55. Bayer Nuclear Medicine Major Business
Table 56. Bayer Nuclear Medicine Total Revenue (USD Million) (2017-2018)
Table 57. Bayer SWOT Analysis
Table 58. Bayer Nuclear Medicine Product and Solutions
Table 59. Bayer Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Eli Lilly Corporate Information, Location and Competitors
Table 61. Eli Lilly Nuclear Medicine Major Business
Table 62. Eli Lilly Nuclear Medicine Total Revenue (USD Million) (2017-2018)
Table 63. Eli Lilly SWOT Analysis
Table 64. Eli Lilly Nuclear Medicine Product and Solutions
Table 65. Eli Lilly Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. China Isotope & Radiation Corporate Information, Location and Competitors
Table 67. China Isotope & Radiation Nuclear Medicine Major Business
Table 68. China Isotope & Radiation Nuclear Medicine Total Revenue (USD Million) (2017-2018)
Table 69. China Isotope & Radiation SWOT Analysis
Table 70. China Isotope & Radiation Nuclear Medicine Product and Solutions
Table 71. China Isotope & Radiation Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Dongcheng Corporate Information, Location and Competitors
Table 73. Dongcheng Nuclear Medicine Major Business
Table 74. Dongcheng Nuclear Medicine Total Revenue (USD Million) (2017-2018)
Table 75. Dongcheng SWOT Analysis
Table 76. Dongcheng Nuclear Medicine Product and Solutions
Table 77. Dongcheng Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Nuclear Medicine Revenue (Million USD) by Players (2015-2020)
Table 79. Global Nuclear Medicine Revenue Share by Players (2015-2020)
Table 80. Global Nuclear Medicine Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Nuclear Medicine Revenue Market Share by Regions (2015-2020)
Table 82. North America Nuclear Medicine Revenue by Countries (2015-2020)
Table 83. North America Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Table 84. Europe Nuclear Medicine Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Nuclear Medicine Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Nuclear Medicine Revenue by Countries (2015-2020)
Table 87. South America Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Nuclear Medicine Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Table 90. Global Nuclear Medicine Revenue (Million USD) by Type (2015-2020)
Table 91. Global Nuclear Medicine Revenue Share by Type (2015-2020)
Table 92. Global Nuclear Medicine Revenue Forecast by Type (2021-2025)
Table 93. Global Nuclear Medicine Revenue by Application (2015-2020)
Table 94. Global Nuclear Medicine Revenue Share by Application (2015-2020)
Table 95. Global Nuclear Medicine Revenue Forecast by Application (2021-2025)
Table 96. Global Nuclear Medicine Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nuclear Medicine Picture
Figure 2. Global Nuclear Medicine Revenue Market Share by Type in 2019
Figure 3. Tc-99 Picture
Figure 4. I-123/131 Picture
Figure 5. In-111 Picture
Figure 6. Xe-133 Picture
Figure 7. Th-201 Picture
Figure 8. Ga-67 Picture
Figure 9. Other Picture
Figure 10. Nuclear Medicine Revenue Market Share by Application in 2019
Figure 11. Diagnostic Picture
Figure 12. Therapeutic Picture
Figure 13. Global Nuclear Medicine Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Nuclear Medicine Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Nuclear Medicine Revenue Market Share in 2019
Figure 22. Global Top 10 Players Nuclear Medicine Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Nuclear Medicine Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Nuclear Medicine Revenue Market Share by Regions (2015-2020)
Figure 26. Global Nuclear Medicine Revenue Market Share by Regions in 2018
Figure 27. North America Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 28. Europe Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 30. South America Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 32. North America Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Figure 33. North America Nuclear Medicine Revenue Market Share by Countries in 2019
Figure 34. USA Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 35. Canada Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 37. Europe Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Nuclear Medicine Revenue Market Share by Countries in 2019
Figure 39. Germany Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 40. UK Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 41. France Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 42. Russia Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 43. Italy Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Nuclear Medicine Revenue Market Share by Countries in 2019
Figure 46. China Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 47. Japan Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 48. Korea Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 49. India Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 51. South America Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Figure 52. South America Nuclear Medicine Revenue Market Share by Countries in 2019
Figure 53. Brazil Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Nuclear Medicine Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Nuclear Medicine Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 58. UAE Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Nuclear Medicine Revenue and Growth Rate (2015-2020)
Figure 61. Global Nuclear Medicine Revenue Share by Type (2015-2020)
Figure 62. Global Nuclear Medicine Revenue Share by Type in 2019
Figure 63. Global Nuclear Medicine Market Share Forecast by Type (2021-2025)
Figure 64. Global Tc-99 Revenue Growth Rate (2015-2020)
Figure 65. Global I-123/131 Revenue Growth Rate (2015-2020)
Figure 66. Global In-111 Revenue Growth Rate (2015-2020)
Figure 67. Global Xe-133 Revenue Growth Rate (2015-2020)
Figure 68. Global Th-201 Revenue Growth Rate (2015-2020)
Figure 69. Global Ga-67 Revenue Growth Rate (2015-2020)
Figure 70. Global Other Revenue Growth Rate (2015-2020)
Figure 71. Global Nuclear Medicine Revenue Share by Application (2015-2020)
Figure 72. Global Nuclear Medicine Revenue Share by Application in 2019
Figure 73. Global Nuclear Medicine Market Share Forecast by Application (2021-2025)
Figure 74. Global Diagnostic Revenue Growth Rate (2015-2020)
Figure 75. Global Therapeutic Revenue Growth Rate (2015-2020)
Figure 76. Global Nuclear Medicine Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Nuclear Medicine Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Nuclear Medicine Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Nuclear Medicine Revenue Market Forecast (2021-2025)
Figure 80. Europe Nuclear Medicine Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Nuclear Medicine Revenue Market Forecast (2021-2025)
Figure 82. South America Nuclear Medicine Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Nuclear Medicine Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
心臓核医学の世界市場（～2026年） Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular di…- 核廃棄物リサイクルの世界市場（～2026年） Nuclear waste is recyclable. Once reactor fuel (uranium or thorium) is used in a reactor, it can be treated and put into another reactor as fuel. More than half of France's electricity comes from nuclear power and recycles used fuel. Other countries that use used fuels include the United Kingdom, Ru…
- 原子力ロボットの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nuclear Robotics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nuclear Robotics market repo…
- 核磁気共鳴分光計（NMR）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Nuclear Magnetic Resonance Spectrometer (NMR) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- 核密度ゲージの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nuclear Density Gauge market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nuclear Density Gauge m…